nociceptin/orphanin FQ receptor agonist (Grunenthal)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namenociceptin/orphanin FQ receptor agonist (Grunenthal)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNociceptin receptor agonists
TargetsNociceptin receptor
Therapy Area/IndicationsDiabetic peripheral neuropathyNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGrunenthal Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesGrunenthal Gmbh
Inactive CompaniesN/A
Active IndicationsDiabetic peripheral neuropathyNeuralgia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A